⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for National Breast and Thyroid Screening After a Treatment Received Against a Cancer During Childhood

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: National Breast and Thyroid Screening After a Treatment Received Against a Cancer During Childhood

Official Title: National Breast and Thyroid Screening After a Treatment Received Against a Cancer During Childhood

Study ID: NCT03183401

Interventions

Study Description

Brief Summary: The DENACAPST programme represents an important initiative to provide near nation-wide roll-out of an important cancer surveillance program for childhood cancer survivors. The program is based on internationally recognized standards in cancer surveillance, which were developed by the International Guideline Harmonization Group (IGHG) with support of all relevant stakeholders in cancer survivorship research and clinical work in Europe, Canada and the United States and recognized French recommendations about breast screening for women at high risk of cancer. With this programme, French centers organized themselves to provide to childhood cancer survivors adequate medical attention, which includes close medical surveillance for breast/thyroid cancer where appropriate, based on adequate risk stratification. The aim of the study is to analyze if the recommendations about breast and thyroid cancer screening are followed in this population and secondly to provide more informations about these second cancers and about the screening.

Detailed Description: Every center which has patient at risk can participate. Main inclusion criteria : French childhood cancer survivor (5 years or more of delay with the treatment) - becoming adult - with a past history of radiotherapy at the age of 20 years or before, with a significant dose irradiation on the thyroid or the breast The inclusion of patients are validated by one team Thyroid screening programme is based on US each 2 years Breast screening programme is based mainly on MRI each year

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Charlotte Demoor-Goldschmidt, Villejuif, , France

Contact Details

Name: charlotte demoor-goldschmidt

Affiliation: Institut National de la Santé Et de la Recherche Médicale, France

Role: PRINCIPAL_INVESTIGATOR

Name: florent de vathaire

Affiliation: Institut National de la Santé Et de la Recherche Médicale, France

Role: PRINCIPAL_INVESTIGATOR

Name: gerard michel

Affiliation: chu

Role: STUDY_CHAIR

Name: pascal auquier

Affiliation: medical university of Marseille

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: